
Harrow Health (HROW) Receives a Buy from Lake Street

Lake Street analyst Brooks O’Neil reiterated a Buy rating on Harrow Health with a price target of $70.00. O’Neil is a 2-star analyst with an average return of 0.2% and a 39.88% success rate. Craig-Hallum’s Chase Knickerbocker also issued a Buy rating, while TR reiterated a Hold rating on Harrow Health.
Lake Street analyst Brooks O’Neil reiterated a Buy rating on Harrow Health today and set a price target of $70.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, O’Neil is a 2-star analyst with an average return of 0.2% and a 39.88% success rate.
In addition to Lake Street, Harrow Health also received a Buy from Craig-Hallum’s Chase Knickerbocker in a report issued on November 12. However, on the same day, TR | OpenAI – 4o reiterated a Hold rating on Harrow Health (NASDAQ: HROW).

